Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?
Meng Qiao, Tao Jiang, Xinyu Liu, Shiqi Mao, Fei Zhou, Xuefei Li, Chao Zhao, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
Topics & Concepts
MedicineImmune systemEpidermal growth factor receptorImmune checkpointCancer researchImmunotherapyEGFR inhibitorsPD-L1Tumor microenvironmentProgrammed cell deathCancerOncologyImmunologyInternal medicineApoptosisBiologyGeneticsCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsCancer Genomics and Diagnostics